PCN20 COSTS OF TREATING ADVANCED NON-SMALL-CELL LUNG CANCER IN SPAIN USING GEMCITABINE IN COMBINATION WITH CISPLATIN- A COMPARISON WITH OTHER 2ND GENERATION NOVEL AGENTS
Abstract
Authors
A Kielhorn T Dilla G Stynes D Tilden S Bhalla